IceCure Medical Ltd
$0.36
▼
-0.33%
2026-04-21 07:26:01
www.icecure-medical.com
NCM: ICCM
Explore IceCure Medical Ltd stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$24.87 M
Current Price
$0.36
52W High / Low
$1.4 / $0.28
Stock P/E
—
Book Value
$0.12
Dividend Yield
—
ROCE
-166.53%
ROE
-1.89%
Face Value
—
EPS
$-0.24
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Devices
Employees
67
Beta
2.52
Debt / Equity
2.4
Current Ratio
2.61
Quick Ratio
2.07
Forward P/E
-4.04
Price / Sales
7.77
Enterprise Value
$14.96 M
EV / EBITDA
-1.01
EV / Revenue
4.43
Rating
Strong Buy
Target Price
$2.73
EPS Forecast (FY)
—
Pros
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
- Valuation is not stretched on P/E basis.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | InfuSystem Holdings, Inc. | $10.79 | 32.21 | $213.43 M | — | 14.83% | 11.54% | $11.04 / $4.66 | $2.84 |
| 2. | LENSAR, Inc. | $5.55 | — | $71.73 M | — | -79.65% | -10.69% | $14.31 / $5.33 | $-2.17 |
| 3. | Avanos Medical, Inc. | $24.64 | — | $1.15 B | — | 1.7% | -9.07% | $24.72 / $9.3 | $16.75 |
| 4. | Integra LifeSciences Holdings Corporation | $11.16 | — | $875.54 M | — | 0.57% | -39.9% | $17.54 / $8.7 | $13.4 |
| 5. | Alphatec Holdings, Inc. | $11.55 | — | $1.68 B | — | -10.13% | -6.31% | $23.29 / $9.89 | $0.08 |
| 6. | Picard Medical, Inc. | $0.9 | — | $69.69 M | — | -344.07% | 270.74% | $13.68 / $0.9 | $0.05 |
| 7. | Pacific Biosciences of California, Inc. | $1.74 | — | $510.38 M | — | -78.39% | -2.13% | $2.73 / $0.85 | $0.02 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | |
|---|---|---|---|---|---|
| Sales | 1.28 M | 0.85 M | 0.53 M | 0.72 M | 0.88 M |
| Operating Profit | -4.22 M | -3.84 M | -3.38 M | -3.66 M | -4.53 M |
| Net Profit | -4.25 M | -3.86 M | -3.36 M | -3.59 M | -4.48 M |
| EPS in Rs | -0.05 | -0.05 | -0.04 | -0.04 | -0.06 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 3.38 M | 3.29 M | 3.23 M | 3.08 M |
| Operating Profit | -15.09 M | -15.7 M | -15.58 M | -16.74 M |
| Net Profit | -15.06 M | -15.32 M | -14.65 M | -16.98 M |
| EPS in Rs | -0.19 | -0.19 | -0.18 | -0.21 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 13.89 M | 12.58 M | 16.41 M | 30.19 M |
| Total Liabilities | 4.84 M | 5.67 M | 4.25 M | 4.77 M |
| Equity | 9.05 M | 6.9 M | 12.16 M | 25.42 M |
| Current Assets | 12.61 M | 10.75 M | 14.18 M | 28.13 M |
| Current Liabilities | 4.82 M | 5.51 M | 3.87 M | 4.34 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | -14.57 M | -12.56 M | -12.55 M | -14.29 M |
| Investing CF | -0.04 M | 0.45 M | -0.68 M | -0.89 M |
| Financing CF | 15.83 M | 9.19 M | 0.08 M | 13.58 M |
| Free CF | -14.61 M | -12.63 M | -13.03 M | -15.18 M |
| Capex | -0.04 M | -0.07 M | -0.48 M | -0.89 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 1.92% | 4.67% | — | — |
| Earnings Growth % | -4.55% | 13.7% | — | — |
| Profit Margin % | -465.45% | -453.76% | -550.34% | — |
| Operating Margin % | -476.94% | -482.38% | -542.59% | — |
| Gross Margin % | 44.09% | 40.26% | 46.84% | — |
| EBITDA Margin % | -466.85% | -472.38% | -534.55% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.